Induction of the estrogen receptor by ablation of DNMT1 in ER-negative breast cancer cells

Cancer Biol Ther. 2003 Sep-Oct;2(5):557-8. doi: 10.4161/cbt.2.5.588.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacology*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / genetics
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases / antagonists & inhibitors*
  • DNA (Cytosine-5-)-Methyltransferases / genetics
  • DNA (Cytosine-5-)-Methyltransferases / metabolism
  • DNA Methylation / drug effects
  • Decitabine
  • Enzyme Inhibitors / pharmacology*
  • Estrogen Receptor alpha
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Oligonucleotides, Antisense / pharmacology*
  • Receptors, Estrogen / biosynthesis*
  • Receptors, Estrogen / genetics

Substances

  • Enzyme Inhibitors
  • Estrogen Receptor alpha
  • Oligonucleotides, Antisense
  • Receptors, Estrogen
  • Decitabine
  • DNA (Cytosine-5-)-Methyltransferase 1
  • DNA (Cytosine-5-)-Methyltransferases
  • DNMT1 protein, human
  • Azacitidine